Puma Biotechnology (PBYI) Net Equity Issued and Repurchased (2010 - 2015)

Puma Biotechnology (PBYI) posted Net Equity Issued and Repurchased of -$63000.0 for Q2 2015, down 100.03% on a QoQ basis from $205.2 million in Q1 2015.

Puma Biotechnology (PBYI) Net Equity Issued and Repurchased (2010 - 2015) Analysis & Trends

Puma Biotechnology's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$63000.0 for Q2 2015.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$63000.0 in Q2 2015, while the trailing twelve-month figure through Dec 2015 was $205.1 million (up 58.48% YoY) and the FY2016 annual result came in at $161.9 million, down 21.1% from the prior year.
  • Net Equity Issued and Repurchased was -$63000.0 for Q2 2015 at Puma Biotechnology, down from $205.2 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $205.2 million in Q1 2015 and bottomed at -$63000.0 in Q2 2015.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Puma Biotechnology 407.27 Mn 368.99 Mn 34.39 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2015 -63,000.00
Jun 30, 2015 -63,000.00
Mar 31, 2015 205.20 Mn
Mar 31, 2015 205.20 Mn
Mar 31, 2014 129.44 Mn
Mar 31, 2014 129.44 Mn
Dec 31, 2010 400.00
Dec 31, 2010 400.00